IRIS
FALCONE, COLOMBA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.255
EU - Europa 4.902
AS - Asia 3.148
OC - Oceania 12
AF - Africa 9
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.194
CN - Cina 3.075
IE - Irlanda 1.468
UA - Ucraina 968
FI - Finlandia 685
DE - Germania 553
IT - Italia 448
SE - Svezia 367
GB - Regno Unito 210
FR - Francia 104
CA - Canada 59
BE - Belgio 49
IN - India 23
NL - Olanda 14
JP - Giappone 13
SG - Singapore 13
AU - Australia 11
MU - Mauritius 8
IR - Iran 7
RU - Federazione Russa 7
CZ - Repubblica Ceca 6
HK - Hong Kong 5
TR - Turchia 5
ES - Italia 4
AR - Argentina 3
AT - Austria 3
EU - Europa 3
RO - Romania 3
SA - Arabia Saudita 3
ID - Indonesia 2
KR - Corea 2
LV - Lettonia 2
MX - Messico 2
PL - Polonia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.334
Salva come PNG Salva come JPEG
Città #
Chandler 1.527
Dublin 1.467
Jacksonville 1.198
Nanjing 866
Nanchang 355
Ashburn 336
Beijing 312
Princeton 279
Hebei 270
Shenyang 262
Lawrence 257
Ann Arbor 256
Medford 239
Changsha 234
Boardman 194
Jiaxing 194
Wilmington 192
Helsinki 181
Tianjin 158
Hangzhou 145
Shanghai 103
Milan 90
New York 90
Woodbridge 68
Seattle 62
Piscataway 58
Toronto 54
Brussels 49
Verona 48
Norwalk 41
Pavia 38
Kunming 32
Des Moines 28
Los Angeles 22
Dearborn 21
Fairfield 20
Jinan 15
Ningbo 14
Zhengzhou 14
Lanzhou 13
Berlin 12
Pune 12
Auburn Hills 11
Houston 11
Palermo 11
Tokyo 11
Rome 10
Washington 10
Changchun 9
Guangzhou 9
San Francisco 9
Tappahannock 9
Falkenstein 8
Singapore 8
Taizhou 8
Canberra 7
Meda 7
Borås 6
Fuzhou 6
Leawood 6
Olomouc 6
Bareggio 5
Brescia 5
Gunzenhausen 5
London 5
Napoli 5
Falls Church 4
Naples 4
Orange 4
Redwood City 4
Amsterdam 3
Andover 3
Bologna 3
Bra 3
Cive 3
Frankfurt am Main 3
Hanover 3
Hefei 3
Latina 3
Melbourne 3
Riyadh 3
Sestri Levante 3
Vienna 3
Zanjan 3
Agrigento 2
Atlanta 2
Buenos Aires 2
Busto Arsizio 2
Cambridge 2
Canyon Country 2
Castelnuovo Rangone 2
Culiacán 2
Cutrofiano 2
Erice 2
Foligno 2
Henderson 2
Mykolayiv 2
Nardò 2
Padova 2
Perugia 2
Totale 10.103
Salva come PNG Salva come JPEG
Nome #
Ruolo dell'infiammazione e della risposta immune nell'aterosclerosi: studio del polimorfismo Asp299Gly del gene TLR4 (Toll Like Receptor 4) in pazienti CAD. 141
Studio di genere: possibile ruolo del polimorfismo Val66Met del BDNF nella malattia coronarica e nella depressione. 138
Riscontro ecocardiografico di apposizioni trombotiche nei pazienti con fibrillazione atriale: predittività del punteggio CHADS2 in relazione alla strategia di prevenzione degli eventi tromboembolici 120
Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia 101
Studio del polimorfismo 14 bp inserzione/delezione nel gene HLA-G e insorgenza della CAD (Coronary Artery Disease) 100
Ruolo dei polimorfismi del gene TNF e dei suoi recettori (TNFR1 e TNFR2) nello sviluppo di aterosclerosi coronarica 94
Analisi molecolare e immunocitochimica dell'espressione del gene RAGE in pazienti CAD (Coronary Artery Disease). 93
Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease 93
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 91
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 88
Infarto miocardico ed età di insorgenza: è implicato il polimorfismo -374T/A del gene RAGE nello studio di genere? 88
Mental stress as a provocative test in patients with various clinical syndromes of coronary heart disease. 87
Age of Onset of Myocardial Infarction: Is Promoter Polymorphism of the RAGE Gene Implicated? 86
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 84
-374 T/A, -429 C/T and G82S polymorphisms of the receptor for advanced glycation endproducts (RAGE) gene (HLA class III) and risk of coronary artery disease (CAD) in Caucasian Italian subjects. 83
Significato prognostico dei livelli plasmatici di osteopontina in pazienti con angina pectoris stabile 83
Atrial fibrillation recurrence and expression levels of apelin-regulating miRNAs 82
Associazione tra il polimorfismo RAGE (Receptor for Advanced Glycation Endproducts) - 374 T/A e la presenza di diabete in soggetti CAD. 81
CAD (Coronary Artery Disease) diabetes and HLA class III RAGE (Receptor for Advanced Glycation End products) gene polymorphisms. 81
Dental pain threshold and excercise-induced silent ischemia in hypertensive and normotensive patients 81
Diabetes mellitus and silent myocardial ischemia in patients with coronary artery disease: comparison between patients with and without simptoms during provocative test. 80
Peripheral benzodiazepine receptor (pBZR) expression on leucocytes in patients with ischemic heart disease 80
RAGE : a central player in nondiabetic vascular disease 79
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 78
Correlation between mucosal levels of receptor for advanced glycation end products (RAGE) with inflammatory indexes in crohn's disease and ulcerative colitis 77
Associazione tra la concentrazione plasmatica di eotaxina e coronaropatia in pazienti sottoposti ad angiografia coronarica 77
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 76
La chemochina regolatoria eotaxina-3 quale nuovo fattore predittivo di outcome cardiovascolare in pazienti con angina pectoris stabile 76
Thrombolisis versus PTCA in patients with recent myocardial infarction: exercise stress echocardiography study 76
Does Nifedipine increased coronary flow during exercise in patients with exertional angina? 74
Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. 74
Effects of physical training on cardiovascular control after heart transplantation 74
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 74
Association between platelet endothelial cellular adhesion molecole 1 ( PECAM-1/CD31) polymorphisms and atherosclerosis: results of a study performed in patients from north Italy 73
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 72
Aterosclerosi e CAD (Coronary artery disease): analisi dei polimorfismi del recettore CR1 72
Improvement in exercise capacity, right heart hemodynamics and right ventricular function after pulmonary endarterectomy in patients with chronic thromoboembolic pulmonary hypertension. 72
Approccio genetico-clinico alla cardiopatia ischemica: analisi di 14 casi familiari. 72
Ruolo prognostico del polimorfismo -374 T/A del gene RAGE (recettore per i prodotti finali di glicazione avanzata) nei pazienti con sospetta coronaropatia 72
A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction 71
Association between platelet endothelial cellular adhesion molecule-1 polymorphisms and atherosclerosis: results of a study on patients from northern Italy 71
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 70
-374T/A and -429 T/C polymorphisms of the RAGE gene in Myocardial Infarction. 70
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 70
Analysis of CR1 and CR2 polymorphisms in Italian patients with angiographically documented coronary artery disease (CAD). 70
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 69
Cateterismo transettale con sistema a radiofrequenza: un nuovo approccio alternativo alla convenzionale puntura del setto con ago d’acciaio 69
Disfunzione erettile come predittore di eventi cardiovascolari maggiori in diabetici con coronaropatia silente angiograficamente documentata 69
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 69
Analisi mutazionale di Kir6.1/KCNJ8 in pazienti con angina vasospastica 69
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects 69
Study of the espression of receptor for advanced glycation end products (RAGE), in inflammatory bowel disease 68
Signal averaged elettrocardiography in patients with chronic ischemic heart disease. 68
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 67
Forma solubile del recettore dei prodotti finali di glicazione avanzata (sRAGE) ed aterosclerosi coronarica 67
Effect of PTCA on hyperventilation induced vasomotor response in stable angina 67
Significance of the walk-through angina phenomenon during exercise testing 67
Relationship between the -374 T/A Rage polymorphism and severity of coronary atherosclerosis 66
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 66
Non-respiratory components of heart rate variability in heart transplant recipients: evidence of autonomic reinnervation? 66
A double comparison of Nicoradil and isosprbide dinitrate slow release in patients with stable angina pectoris 66
Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. 65
Factors moduleting respiratory sinus arrhytmia during physical exercise in heart transplanted patients 65
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk 65
Role of TNF and its receptors (TNFR1, TNFR2) in Coronary Artery Disease (CAD). 64
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension 64
Gene RAGE e cardiopatia ischemica: ruolo del polimorfismo –374 T/A nell’estensione della coronaropatia 64
Therapeutic approach in patients with stable angina 63
Exercise stress echocardiography i patientswith and without angina during myocardial ischemia. 63
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients 62
Polimorfismi del gene RAGE (Receptor for Advanced Glycation Endproducts) e CAD (Coronary Artery Disease): studio dell'implicazione nell'eterogeneità di malattia 62
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 62
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 62
Correlazione tra normalizzazione emodinamica e recupero funzionale nei pazienti sottoposti a tromboendoarteriectomia polmonare per ipertensione polmonare cronica tromboembolica 62
Ormonoterapia e cardiopatia ischemica nella donna in menopausa. 62
Peripheral benzodiazepine receptors expression on leucocytes in patients with ischemic heart disease 62
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 62
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism 62
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 61
Il six minute walking test è un indice attendibile nella valutazione del recupero funzionale nei pazienti con cuore polmonare cronico tromboembolico sottoposti ad endoarteriectomia polmonare 61
Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms 61
Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism 61
Studio dei polimorfismi nel gene del recettore dell’apelina in pazienti con e senza ipertensione arteriosa 61
Transcutaneous Oxygen Tension as a Potential Predictor of Cardiovascular Events in Type 2 Diabetes: Comparison with ankle-brachial index 61
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 61
Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia 61
Association between the -374 T/A polymorphism of RAGE gene and coronary artery disease 61
Associazione tra i polimorfismi della molecola di adesione PECAM-1/CD31 ed aterosclerosi: risultati di uno studio condotto in pazienti dell'Italia del nord. 60
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target 60
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. 60
Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients 60
POLIMORFISMO DEL GENE RAGE E MANIFESTAZIONI CLINICHE DELLA CARDIOPATIA ISCHEMICA 60
Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina 60
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 59
Relationship between the -374 T/A RAGE gene polymorphism and angiographic coronary artery disease 58
CD14 polymorphisms and ACS (Acute Coronary Syndromes) 58
Exercise-induced coronary artery spasm. A regional coronary blood flow study 58
Increased production of inflammatory cytokines in patients with silent myocardial ischemia 58
Association between two polymorphisms in the HLA-G gene and angiographic coronaryartery disease 58
A case of "torsade de pointe" during vincamine therapy 58
Totale 7.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.731 1.022 1.489 14 190 11 214 39 205 21 330 185 11
2020/20211.797 207 167 58 189 14 246 23 249 62 272 244 66
2021/20221.198 22 8 50 22 8 40 18 59 62 37 185 687
2022/20234.306 479 321 49 353 482 415 2 279 1.746 44 85 51
2023/20241.314 177 237 49 107 95 326 13 113 11 32 99 55
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 14.409